Today’s Stock Market in 2-Minutes
April 25, 2024
Lexaria’s Human Clinical Nicotine Study Completes Dosing as Planned
May 8, 2023
Related Post
-
-
Cyngn Announces Closing of $5.0 Million Firm Commitment Public Offering of Common Stock
April 25, 2024
-
Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
April 25, 2024
-
Byrna Technologies Promotes John Brasseur to Chief Operating Officer and Raises Production Target to 18,000 Launchers per Month
April 25, 2024